Anti-CD25, Mouse-Mono(B-B10), Azide free <Anti-IL-2R α Chain>

データシート※最新のデータシートでない場合があります

• 商品コード：852.000.000
• メーカー：TLS
• 包装：200μl
• 本製品は取扱中止になりました

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Groux H et al. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J. Immunol. 1998 Apr;160(7):3188-93
  Groux H et al
  1998/01/01
  
• 備考：
  Application: Inhibition
• 参照：
  

• No.： 2
• 文献情報：
  Ozsahin H et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 1998 Oct;92(8):2719-24
  Ozsahin H et al
  1998/01/01
  
• 備考：
  Application: Inhibition
• 参照：
  

• No.： 3
• 文献情報：
  Oppmann B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000 Nov;13(5):715-25
  Oppmann B et al
  2000/01/01
  
• 備考：
  Application: Inhibition of proliferation
• 参照：
  

• No.： 4
• 文献情報：
  Herv辿 P et al. Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) Blood 1990 Feb;75(4):1017-23
  Herv辿 P et al
  1990/01/01
  
• 備考：
  Application: Inhibition of T-cell proliferation
• 参照：
  

• No.： 5
• 文献情報：
  Agostini C et al. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome. Blood 1997 Aug;90(3):1115-23
  Agostini C et al
  1997/01/01
  
• 備考：
  Application: Inhibition of T-Cells
• 参照：
  

• No.： 6
• 文献情報：
  Racadot E et al. Outcome of lymphocyte subsets and cytokines during combined CD4/anti-IL-2R monoclonal antibody therapy in kidney transplantation. Transplant. Proc. 1995 Apr;27(2):1672-3
  Racadot E et al
  1995/01/01
  
• 備考：
  Application: No paper available
• 参照：
  

• No.： 7
• 文献情報：
  Mousson C et al. CD4 and CD25 monoclonal antibody cocktail in kidney transplant rejection prophylaxis: clinical results of a pilot study. Transplant. Proc. 1995 Apr;27(2):1727-8
  Mousson C et al
  1995/01/01
  
• 備考：
  Application: Nothing available
• 参照：
  

• No.： 8
• 文献情報：
  Regeer RR et al. A dileucine motif targets the sulfate anion transporter sat-1 to the basolateral membrane in renal cell lines. Am. J. Physiol., Cell Physiol. 2004 Aug;287(2):C365-72
  Regeer RR et al
  2004/01/01
  
• 備考：
  Application: Primary antibody in immunoflourescence study
• 参照：
  

• No.： 9
• 文献情報：
  Nevill TJ et al. Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation. Blood 1998 Sep;92(6):1910-7
  Nevill TJ et al
  1998/01/01
  
• 備考：
  Application: T-cell inhibition
• 参照：
  

• No.： 10
• 文献情報：
  Engert A et al. Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice. Int. J. Cancer 1991 Sep;49(3):450-6
  Engert A et al
  1991/01/01
  
• 備考：
  
• 参照：
  

• No.： 11
• 文献情報：
  Herbelin C et al. Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants. Bone Marrow Transplant.
  Herbelin C et al
  1994/01/01
  
• 備考：
  
• 参照：
  

• No.： 12
• 文献情報：
  Herv辿 P et al. Treatment of acute graft-versus-host disease with monoclonal antibody to IL-2 receptor. Lancet 1988 Nov;2(8619):1072-3
  Herv辿 P et al
  1988/01/01
  
• 備考：
  
• 参照：
  

• No.： 13
• 文献情報：
  Heyll A et al. [Therapy of multiple myeloma by allogeneic bone marrow transplantation]. Dtsch. Med. Wochenschr. 1991 May;116(22):852-6
  Heyll A et al
  1991/01/01
  
• 備考：
  
• 参照：
  

• No.： 14
• 文献情報：
  Racadot E et al. Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients. Bone Marrow Transplant. 1995 May;15(5):669-77
  Racadot E et al
  1995/01/01
  
• 備考：
  
• 参照：
  

• No.： 15
• 文献情報：
  Nakatani T et al. Humanization of mouse anti-human IL-2 receptor antibody B-B10. Protein Eng. 1994 Mar;7(3):435-43
  Nakatani T et al
  1994/01/01
  
• 備考：
  
• 参照：
  

• No.： 16
• 文献情報：
  Tiberghien P et al. Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatment. Transplantation 1991 Sep;52
  Tiberghien P et al
  1991/01/01
  
• 備考：
  
• 参照：
  

• No.： 17
• 文献情報：
  Tazzari PL et al. B-B10 (anti-CD25)-saporin immunotoxin--a possible tool in graft-versus-host disease treatment. Transplantation 1992 Aug;54(2):351-6
  Tazzari PL et al
  1992/01/01
  
• 備考：
  
• 参照：
  

• No.： 18
• 文献情報：
  Wijdenes J et al. A semi-pharmaceutical approach for the preparation of an anti-IL2 receptor monoclonal antibody in the treatment of acute GvHD in a multicentric study. Dev. Biol. Stand. 1990;71:103-11
  Wijdenes J et al
  1990/01/01
  
• 備考：
  
• 参照：